Martin M. Okun
Publications by Year
Research Areas
Hidradenitis Suppurativa and Treatments, Psoriasis: Treatment and Pathogenesis, Colorectal and Anal Carcinomas, Dermatology and Skin Diseases, Anorectal Disease Treatments and Outcomes
Most-Cited Works
- → Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial(2007)872 cited
- → Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa(2016)753 cited
- → Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study(2006)506 cited
- → Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa(2012)407 cited
- → The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study(2006)208 cited
- → Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment(2014)206 cited
- → Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study(2018)184 cited
- → What causes hidradenitis suppurativa ?—15 years after(2020)181 cited
- → Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy(2010)114 cited
- → Impact of adalimumab treatment on patient‐reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis(2007)102 cited